Short answer

Thai FDA regulates medical devices, including software, under the Medical Device Act B.E. 2551 (2008), as amended in 2019, with four risk classes. A foreign manufacturer works through a Thai importer, which files the application and acts as the local regulatory contact. Your EU MDR certificate and technical documentation serve as evidence, but we could not confirm a Thai FDA route that shortens the review on the strength of an EU certificate alone. The confirmed shortcut runs via Malaysia: since 1 May 2026, devices approved by MDA skip Thai FDA’s external expert evaluation, so EU-certified companies can plan EU MDR, then Malaysia, then Thailand.

Thailand's regulatory framework for medical devices

Thailand's Food and Drug Administration (Thai FDA), part of the Ministry of Public Health, regulates medical devices under the Medical Device Act B.E. 2551 (2008), as amended by the Medical Device Act (No. 2) B.E. 2562 (2019), and the ministerial notifications issued under it.

Software is regulated as a medical device when its intended purpose meets the Act's definition of a medical device. Thailand classifies medical devices into four risk classes under a 2019 ministerial notification: Class 1 (lowest risk); Classes 2 and 3, which are registered by detailed notification; and Class 4 (highest risk), which requires a licence. Industry summaries of Thai FDA's SaMD guidance describe software as falling into Class 1 or Classes 2–3; confirm the class of your software for its intended purpose before you submit.

Thai FDA's SaMD-specific guidance

Thai FDA has published guidance on registering SaMD. Industry sources report that it was issued in May 2024 and that it lists separate document sets for Class 1 and for Class 2–3 software, with expectations on cybersecurity and personal data protection for connected software and on transparency of AI/ML processes. We could not open the Thai FDA page from here, so check the current version on Thai FDA's medical device website before relying on any checklist.

For Class 2 and Class 3 SaMD, industry summaries of the guidance list documents such as:

  • Product description and intended use: a specific statement of the intended medical purpose, user population and clinical context
  • Essential principles and verification and validation summary: including software verification and validation — your EU MDR technical documentation and clinical evaluation are the source
  • Risk analysis: your ISO 14971 risk management file
  • Quality system certificate: ISO 13485 or equivalent QMS evidence
  • Foreign registration history: for example your EU MDR certificate
  • Cybersecurity documentation: for connected SaMD, cybersecurity and personal data protection measures
  • Declaration of conformity and power of attorney from the manufacturer to the Thai importer

The Malaysia–Thailand regulatory reliance programme

Malaysia's Medical Device Authority (MDA) and Thai FDA signed a confidentiality agreement at the 29th GHWP Annual Meeting in Bangkok on 4 December 2025 and piloted a medical device regulatory reliance programme from 1 February to 30 April 2026. In a joint announcement of 1 May 2026 the two regulators moved it to full implementation, with immediate effect, for Class B, C and D devices:

  • Devices approved by Thai FDA can use MDA's verification route instead of a full evaluation (MDA/GD/0070).
  • Devices approved by MDA can skip Thai FDA's external expert evaluation that would otherwise follow a full CSDT submission.

No processing times were published with the announcement. For an EU MDR certified SaMD, the practical sequence is to register in Malaysia using your EU certificate through MDA's verification route — see our Malaysia MDA registration guide — and then use the MDA registration for the Thai submission. A Singapore registration fits into the same chain, because MDA also accepts SMDR listings for verification. Our Singapore HSA and Malaysia MDA registration service covers that first step for EU-certified software.

Status (October 2026): according to the joint MDA–Thai FDA announcement, the programme has been in full implementation since 1 May 2026. The announcement also refers to Thai FDA implementing documents, including a draft notification on recognised reference agencies — check their final status with your Thai importer before you plan around them.
Looking at Thailand alongside Malaysia or Singapore? I can map Thai FDA requirements against the documentation you already have and help you plan the route and dossier with your local partner.
Request a free call →

Standard Thai FDA registration process for EU MDR certified SaMD

Outside the reliance programme, you register through Thai FDA's standard route, with your EU MDR certificate as evidence of foreign registration. Industry sources also describe a Thai FDA "concise evaluation" route for Class 2–4 devices approved by a reference regulator (reported to include the EU); we could not confirm it on a Thai FDA page, so ask your importer whether it is available for your device.

  1. Appoint a Thai importer: under the Medical Device Act, registration is applied for by the Thai manufacturer or importer, so a foreign manufacturer works through a Thai importer that files the application. Check your importer's Thai FDA licensing status for medical device imports.
  2. Confirm the Thai device class: determine the Thai class (1–4) for your intended purpose before submission — it can differ from your EU class.
  3. Prepare the Thai submission package: a CSDT-based dossier following Thai FDA's SaMD guidance — product description, risk analysis, QMS certificate, foreign registration history (EU MDR certificate), verification and validation evidence, cybersecurity documentation for connected SaMD, Thai-compliant labelling, and a power of attorney from the manufacturer to the Thai importer.
  4. Submit electronically: your Thai importer files the application through Thai FDA's electronic submission system.
  5. Plan the timing: review time depends on the class, dossier quality, query rounds and whether external expert evaluation is needed. We do not quote a figure because we could not confirm current official timelines; the MDA reliance route removes the external expert evaluation for MDA-approved devices.

Thai labelling requirements for SaMD

Thailand has replaced its medical device labelling rules with a new Ministry of Public Health notification issued in 2025. Industry summaries report that it applies from 20 June 2026, that labels and IFU for professional-use devices may be in Thai or English while home-use devices need Thai, and that software may use fully electronic labels and IFU. We could not open the official text from here — confirm the requirements for your device with your importer before finalising labels. For the wider regional picture, see our ASEAN market entry guide.

Official sources & references